Regulation of tau pathology by the microglial fractalkine receptor

Kiran Bhaskar, Megan Konerth, Olga N. Kokiko-Cochran, Astrid Cardona, Richard M. Ransohoff, Bruce T. Lamb

Research output: Contribution to journalArticle

287 Scopus citations

Abstract

Aggregates of the hyperphosphorylated microtubule-associated protein tau (MAPT) are an invariant neuropathological feature of tauopathies. Here, we show that microglial neuroinflammation promotes MAPT phosphorylation and aggregation. First, lipopolysaccharide-induced microglial activation promotes hyperphosphorylation of endogenous mouse MAPT in nontransgenic mice that is further enhanced in mice lacking the microglial-specific fractalkine receptor (CX3CR1) and is dependent upon functional toll-like receptor 4 and interleukin-1 (IL-1) receptors. Second, humanized MAPT transgenic mice lacking CX3CR1 exhibited enhanced MAPT phosphorylation and aggregation as well as behavioral impairments that correlated with increased levels of active p38 MAPK. Third, in vitro experiments demonstrate that microglial activation elevates the level of active p38 MAPK and enhances MAPT hyperphosphorylation within neurons that can be blocked by administration of an interleukin-1 receptor antagonist and a specific p38 MAPK inhibitor. Taken together, our results suggest that CX3CR1 and IL-1/p38 MAPK may serve as novel therapeutic targets for human tauopathies.

Original languageEnglish (US)
Pages (from-to)19-31
Number of pages13
JournalNeuron
Volume68
Issue number1
DOIs
StatePublished - Oct 6 2010

    Fingerprint

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010). Regulation of tau pathology by the microglial fractalkine receptor. Neuron, 68(1), 19-31. https://doi.org/10.1016/j.neuron.2010.08.023